{"transactions":[{"id":4613787,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-06","kind":"exercise","planned":false,"acquired":false,"shares":3455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":6912,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3455},"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":4613786,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-05","kind":"exercise","planned":false,"acquired":false,"shares":4109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":12330,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":4109},"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":4613785,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":17251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter."}],"balance_after":17251,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":17251},"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":4613784,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1854,"price":386.11,"value":715847.94,"ownership":{"direct":true},"balance_after":449019,"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":4613783,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-06","kind":"exercise","planned":false,"acquired":true,"shares":3455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":450873,"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":4613782,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2876,"price":386.11,"value":1110452.36,"ownership":{"direct":true},"balance_after":447418,"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":4613781,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-09T22:42:11.000Z","date":"2026-09-05","kind":"exercise","planned":false,"acquired":true,"shares":4109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":450294,"source":{"system":"sec-edgar","filing":"0000940805-26-000004","document":"wk-form4_1788993728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000004/wk-form4_1788993728.xml","form_type":"4"}},{"id":3218,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T21:35:58.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3005,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0000940805-26-000002","document":"wk-form4_1788471355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000002/wk-form4_1788471355.xml","form_type":"4"}},{"id":3217,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T21:35:58.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2082},"source":{"system":"sec-edgar","filing":"0000940805-26-000002","document":"wk-form4_1788471355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000002/wk-form4_1788471355.xml","form_type":"4"}},{"id":3216,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-03T21:35:58.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2336,"price":380.96,"value":889922.56,"ownership":{"direct":true},"balance_after":446185,"source":{"system":"sec-edgar","filing":"0000940805-26-000002","document":"wk-form4_1788471355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000002/wk-form4_1788471355.xml","form_type":"4"}},{"id":3215,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-03T21:35:58.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":5087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":448521,"source":{"system":"sec-edgar","filing":"0000940805-26-000002","document":"wk-form4_1788471355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/940805/000094080526000002/wk-form4_1788471355.xml","form_type":"4"}},{"id":1045490,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-09-09T20:19:59.000Z","date":"2025-09-06","kind":"exercise","planned":false,"acquired":false,"shares":3455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":10367,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3455},"source":{"system":"sec-edgar","filing":"0000940805-25-000006","document":"wk-form4_1757449196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000006/wk-form4_1757449196.xml","form_type":"4"}},{"id":1045489,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-09-09T20:19:59.000Z","date":"2025-09-05","kind":"grant","planned":false,"acquired":true,"shares":16439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":16439,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":16439},"source":{"system":"sec-edgar","filing":"0000940805-25-000006","document":"wk-form4_1757449196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000006/wk-form4_1757449196.xml","form_type":"4"}},{"id":1045488,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-09-09T20:19:59.000Z","date":"2025-09-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1528,"price":295.43,"value":451417.04,"ownership":{"direct":true},"balance_after":443434,"source":{"system":"sec-edgar","filing":"0000940805-25-000006","document":"wk-form4_1757449196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000006/wk-form4_1757449196.xml","form_type":"4"}},{"id":1045487,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-09-09T20:19:59.000Z","date":"2025-09-06","kind":"exercise","planned":false,"acquired":true,"shares":3455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":444962,"source":{"system":"sec-edgar","filing":"0000940805-25-000006","document":"wk-form4_1757449196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000006/wk-form4_1757449196.xml","form_type":"4"}},{"id":1051012,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-09-03T22:00:53.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":6010,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0000940805-25-000004","document":"wk-form4_1756936850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000004/wk-form4_1756936850.xml","form_type":"4"}},{"id":1051011,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-09-03T22:00:53.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2082,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2082},"source":{"system":"sec-edgar","filing":"0000940805-25-000004","document":"wk-form4_1756936850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000004/wk-form4_1756936850.xml","form_type":"4"}},{"id":1051010,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-09-03T22:00:53.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1266},"source":{"system":"sec-edgar","filing":"0000940805-25-000004","document":"wk-form4_1756936850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000004/wk-form4_1756936850.xml","form_type":"4"}},{"id":1051009,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-09-03T22:00:53.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3084,"price":297.88,"value":918661.92,"ownership":{"direct":true},"balance_after":441507,"source":{"system":"sec-edgar","filing":"0000940805-25-000004","document":"wk-form4_1756936850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000004/wk-form4_1756936850.xml","form_type":"4"}},{"id":1051008,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-09-03T22:00:53.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":444591,"source":{"system":"sec-edgar","filing":"0000940805-25-000004","document":"wk-form4_1756936850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000094080525000004/wk-form4_1756936850.xml","form_type":"4"}},{"id":1225558,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-05T22:03:00.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":11671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":11671,"derivative":{"exercise_price":256.45,"expiration_date":"2035-03-03","underlying":"Bio-Rad A Common Stock","underlying_shares":11671},"source":{"system":"sec-edgar","filing":"0001062993-25-004609","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325004609/form4.xml","form_type":"4"}},{"id":1411570,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2024-09-10T18:07:05.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":13822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":13822,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":13822},"source":{"system":"sec-edgar","filing":"0001062993-24-016388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016388/form4.xml","form_type":"4"}},{"id":1417316,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":false,"shares":2320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2320},"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417315,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":false,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1805},"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417314,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1266,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1266},"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417313,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":4164,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2081},"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417312,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":9015,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417311,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1241,"price":334.31,"value":414878.71,"ownership":{"direct":true},"balance_after":438238,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417310,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":true,"shares":2320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":439479,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417309,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":965,"price":337.32,"value":325513.8,"ownership":{"direct":true},"balance_after":437159,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417308,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":true,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":438124,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417307,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":545,"price":337.32,"value":183839.4,"ownership":{"direct":true},"balance_after":436319,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417306,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":436864,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417305,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":801,"price":337.32,"value":270193.32,"ownership":{"direct":true},"balance_after":435598,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417304,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":436399,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417303,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1607,"price":337.32,"value":542073.24,"ownership":{"direct":true},"balance_after":434318,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1417302,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:35:00.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":435925,"source":{"system":"sec-edgar","filing":"0001062993-24-016174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016174/form4.xml","form_type":"4"}},{"id":1421494,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2024-08-28T23:45:57.000Z","date":"2024-08-26","kind":"gift","planned":false,"acquired":true,"shares":57,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares."}],"balance_after":13006,"source":{"system":"sec-edgar","filing":"0001062993-24-015816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324015816/form4.xml","form_type":"4"}},{"id":1421493,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2024-08-28T23:45:57.000Z","date":"2024-08-26","kind":"gift","planned":false,"acquired":true,"shares":57,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":361466,"source":{"system":"sec-edgar","filing":"0001062993-24-015816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324015816/form4.xml","form_type":"4"}},{"id":1583324,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-12T16:23:18.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":14137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":14137,"derivative":{"exercise_price":343.76,"expiration_date":"2034-03-08","underlying":"Bio-Rad A Common Stock","underlying_shares":14137},"source":{"system":"sec-edgar","filing":"0001062993-24-006216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324006216/form4.xml","form_type":"4"}},{"id":1719689,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-12-08T00:14:24.000Z","date":"2023-12-05","kind":"gift","planned":false,"acquired":true,"shares":49,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares."}],"balance_after":12949,"source":{"system":"sec-edgar","filing":"0001062993-23-022114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323022114/form4.xml","form_type":"4"}},{"id":1719688,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-12-08T00:14:24.000Z","date":"2023-12-05","kind":"gift","planned":false,"acquired":true,"shares":49,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":361409,"source":{"system":"sec-edgar","filing":"0001062993-23-022114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323022114/form4.xml","form_type":"4"}},{"id":1752261,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing a right to purchase a total of 15,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":159.32,"expiration_date":"2026-09-07","underlying":"Bio-Rad B Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752260,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing a right to purchase a total of 16,000 shares, became exercisable in five equal annual installments beginning on September 11, 2016, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":139.56,"expiration_date":"2025-09-11","underlying":"Bio-Rad B Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752259,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 35,000 shares, became exercisable in five equal annual installments beginning on September 10, 2015, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":119.8,"expiration_date":"2024-09-10","underlying":"Bio-Rad B Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752258,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":12024,"price":273,"value":3282552.0,"ownership":{"direct":true},"balance_after":361360,"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752257,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":159.32,"value":2389800.0,"ownership":{"direct":true},"balance_after":373384,"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752256,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":12274,"price":273,"value":3350802.0,"ownership":{"direct":true},"balance_after":358384,"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752255,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":139.56,"value":2232960.0,"ownership":{"direct":true},"balance_after":370658,"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752254,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":25642,"price":273,"value":7000266.0,"ownership":{"direct":true},"balance_after":354658,"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1752253,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-11-02T15:28:27.000Z","date":"2023-11-01","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":119.8,"value":4193000.0,"ownership":{"direct":true},"balance_after":380300,"source":{"system":"sec-edgar","filing":"0001062993-23-020015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323020015/form4.xml","form_type":"4"}},{"id":1788434,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T16:50:36.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":12020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":12020,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":12020},"source":{"system":"sec-edgar","filing":"0001062993-23-017634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017634/form4.xml","form_type":"4"}},{"id":1795915,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option, representing a right to purchase a total of 39,000 shares, became exercisable in five equal annual installments beginning on September 11, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":117.5,"expiration_date":"2023-09-11","underlying":"Bio-Rad B Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795914,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795913,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":2320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."}],"balance_after":2320,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2320},"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795912,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."}],"balance_after":1805,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1805},"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795911,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."}],"balance_after":2532,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1266},"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795910,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant."}],"balance_after":6245,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2081},"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795909,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":25389,"price":381.78,"value":9693012.42,"ownership":{"direct":true},"balance_after":345300,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795908,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":39000,"price":117.5,"value":4582500.0,"ownership":{"direct":true},"balance_after":370689,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795907,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1290,"price":381.78,"value":492496.2,"ownership":{"direct":true},"balance_after":432920,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795906,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":434210,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795905,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1151,"price":381.78,"value":439428.78,"ownership":{"direct":true},"balance_after":431610,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795904,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":2320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":432761,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795903,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":895,"price":381.78,"value":341693.1,"ownership":{"direct":true},"balance_after":430441,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795902,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":431336,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795901,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":628,"price":381.78,"value":239757.84,"ownership":{"direct":true},"balance_after":429531,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795900,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":430159,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795899,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1032,"price":381.78,"value":393996.96,"ownership":{"direct":true},"balance_after":428893,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":1795898,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-08-28T17:29:48.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":429925,"source":{"system":"sec-edgar","filing":"0001062993-23-017146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017146/form4.xml","form_type":"4"}},{"id":2101053,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2022-12-01T21:35:23.000Z","date":"2022-11-07","kind":"gift","acquired":true,"shares":42,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares."}],"balance_after":12900,"source":{"system":"sec-edgar","filing":"0001062993-22-023089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322023089/form4.xml","form_type":"4"}},{"id":2101052,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2022-12-01T21:35:23.000Z","date":"2022-11-07","kind":"gift","acquired":true,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":331689,"source":{"system":"sec-edgar","filing":"0001062993-22-023089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322023089/form4.xml","form_type":"4"}},{"id":2164970,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-05","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164969,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-04","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2600,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164968,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-03","kind":"exercise","acquired":false,"shares":2319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":4640,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2319},"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164967,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3610,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1805},"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164966,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-05","kind":"tax_withholding","acquired":false,"shares":1575,"price":478.32,"value":753354.0,"ownership":{"direct":true},"balance_after":427844,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164965,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-05","kind":"exercise","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":429419,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164964,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-04","kind":"tax_withholding","acquired":false,"shares":1575,"price":478.32,"value":753354.0,"ownership":{"direct":true},"balance_after":426819,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164963,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-04","kind":"exercise","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":428394,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164962,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-03","kind":"tax_withholding","acquired":false,"shares":1405,"price":478.32,"value":672039.6,"ownership":{"direct":true},"balance_after":425794,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164961,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-03","kind":"exercise","acquired":true,"shares":2319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":427199,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164960,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":1094,"price":478.32,"value":523282.08,"ownership":{"direct":true},"balance_after":424880,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2164959,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:24:53.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":425974,"source":{"system":"sec-edgar","filing":"0001062993-22-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019290/form4.xml","form_type":"4"}},{"id":2166872,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T18:10:23.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3798,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1266},"source":{"system":"sec-edgar","filing":"0001062993-22-019202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019202/form4.xml","form_type":"4"}},{"id":2166871,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T18:10:23.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":8326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":8326,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":8326},"source":{"system":"sec-edgar","filing":"0001062993-22-019202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019202/form4.xml","form_type":"4"}},{"id":2166870,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-06T18:10:23.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":767,"price":486.25,"value":372953.75,"ownership":{"direct":true},"balance_after":424169,"source":{"system":"sec-edgar","filing":"0001062993-22-019202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019202/form4.xml","form_type":"4"}},{"id":2166869,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-06T18:10:23.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":424936,"source":{"system":"sec-edgar","filing":"0001062993-22-019202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019202/form4.xml","form_type":"4"}},{"id":2172553,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-29T23:45:05.000Z","date":"2022-08-26","kind":"exercise","acquired":false,"shares":39250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 39,250 shares, became exercisable in five equal annual installments beginning on September 12, 2013, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":107.32,"expiration_date":"2022-09-12","underlying":"Bio-Rad B Common Stock","underlying_shares":39250},"source":{"system":"sec-edgar","filing":"0001062993-22-018842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322018842/form4.xml","form_type":"4"}},{"id":2172552,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2022-08-29T23:45:05.000Z","date":"2022-08-26","kind":"tax_withholding","acquired":false,"shares":23749,"price":495.28,"value":11762404.72,"ownership":{"direct":true},"balance_after":331647,"source":{"system":"sec-edgar","filing":"0001062993-22-018842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322018842/form4.xml","form_type":"4"}},{"id":2172551,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2022-08-29T23:45:05.000Z","date":"2022-08-26","kind":"exercise","acquired":true,"shares":39250,"price":107.32,"value":4212310.0,"ownership":{"direct":true},"balance_after":355396,"source":{"system":"sec-edgar","filing":"0001062993-22-018842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322018842/form4.xml","form_type":"4"}},{"id":2499911,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2021-11-23T19:30:23.000Z","date":"2021-11-09","kind":"gift","acquired":true,"shares":20,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares."}],"balance_after":12858,"source":{"system":"sec-edgar","filing":"0001062993-21-011448","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321011448/form4.xml","form_type":"4"}},{"id":2499910,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2021-11-23T19:30:23.000Z","date":"2021-11-09","kind":"gift","acquired":true,"shares":20,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":316146,"source":{"system":"sec-edgar","filing":"0001062993-21-011448","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321011448/form4.xml","form_type":"4"}},{"id":2575530,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-09T13:39:31.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, representing a right to purchase a total of 37,000 shares, became exercisable in five equal annual installments beginning on November 4, 2012, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":100.06,"expiration_date":"2021-11-04","underlying":"Bio-Rad B Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001062993-21-008418","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008418/form4.xml","form_type":"4"}},{"id":2575529,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-09-09T13:39:31.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 7, 2016, the reporting person was granted 15,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 7, 2016, the reporting person was granted 15,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad B Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001062993-21-008418","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008418/form4.xml","form_type":"4"}},{"id":2575528,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2021-09-09T13:39:31.000Z","date":"2021-09-07","kind":"tax_withholding","acquired":false,"shares":20660,"price":806.32,"value":16658571.2,"ownership":{"direct":true},"balance_after":316126,"source":{"system":"sec-edgar","filing":"0001062993-21-008418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008418/form4.xml","form_type":"4"}},{"id":2575527,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2021-09-09T13:39:31.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":37000,"price":100.06,"value":3702220.0,"ownership":{"direct":true},"balance_after":336786,"source":{"system":"sec-edgar","filing":"0001062993-21-008418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008418/form4.xml","form_type":"4"}},{"id":2575526,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2021-09-09T13:39:31.000Z","date":"2021-09-07","kind":"tax_withholding","acquired":false,"shares":1488,"price":806.32,"value":1199804.16,"ownership":{"direct":true},"balance_after":299786,"source":{"system":"sec-edgar","filing":"0001062993-21-008418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008418/form4.xml","form_type":"4"}},{"id":2575525,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Bio-Rad B Common Stock","published_at":"2021-09-09T13:39:31.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class B common stock acquired on the vesting of restricted stock units."}],"balance_after":301274,"source":{"system":"sec-edgar","filing":"0001062993-21-008418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008418/form4.xml","form_type":"4"}},{"id":2576789,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":2248,"kind":"person","name":"SCHWARTZ NORMAN D","position":1,"cik":"0000940805","reported_name":"SCHWARTZ NORMAN D","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, President, and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-09-08T16:09:26.000Z","date":"2021-09-05","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2600,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001062993-21-008356","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008356/form4.xml","form_type":"4"}}],"next_cursor":"2021-09-08T16:09:26.000000Z,2576789"}